End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
781,000 KRW | -0.76% | +1.30% | +2.76% |
05-06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
04-25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.76% | 40.9B | |
-2.35% | 89.08B | |
-12.92% | 32.25B | |
+54.69% | 25.14B | |
-16.51% | 15.39B | |
-8.27% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B | |
-7.60% | 8.62B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- UBS Starts Samsung Biologics at Buy With 1,070,000 Won Price Target